Search

Displaying results 8751 - 8760 of 10000 in total
  1. Drug

    Lactoferrin

    go.drugbank.com/drugs/DB16555
    Investigational

    Lactoferrin is under investigation in clinical trial NCT03748043 (The Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis).

  2. Drug

    Quaratusugene ozeplasmid

    go.drugbank.com/drugs/DB19231
    Investigational

    Quaratusugene ozeplasmid is under investigation in clinical trial NCT05062980 (Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-small Lung Cancer).

  3. Drug

    PLX51107

    go.drugbank.com/drugs/DB17543
    Investigational

    [A257246,A257251] PLX51107 is under investigation in clinical trial NCT04022785 (PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome). … PLX51107 is a potent and selective inhibitor of the bromodomain and extraterminal (BET) protein family.

  4. Drug

    Zosurabalpin

    go.drugbank.com/drugs/DB21539
    Investigational

    Zosurabalpin is a small molecule drug. … Zosurabalpin is under investigation in clinical trial NCT05614895 (A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections).

  5. Drug

    DCFBC F-18

    go.drugbank.com/drugs/DB14772
    Investigational

    DCFBC F-18 is under investigation in clinical trial NCT02190279 (18F-DCFBC PET/CT in Prostate Cancer).

  6. Drug

    Modotuximab

    go.drugbank.com/drugs/DB14827
    Investigational

    Modotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab in Patients With mCRC).

  7. Drug

    Narnatumab

    go.drugbank.com/drugs/DB14964
    Investigational

    Narnatumab is under investigation in clinical trial NCT01119456 (A Study of IMC-RON8 in Advanced Solid Tumors).

  8. Drug

    BI 44370 TA

    go.drugbank.com/drugs/DB16037
    Investigational

    BI 44370 TA is under investigation in clinical trial NCT00751803 (BI 44370 TA in Acute Migraine Attack).

  9. Drug

    DU125530

    go.drugbank.com/drugs/DB16040
    Investigational

    DU125530 is under investigation in clinical trial NCT01119430 (Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder).

    Categories: Serotonin Receptor Antagonists, Serotonin 5-HT1 Receptor Antagonists
  10. Drug

    GP2 peptide

    go.drugbank.com/drugs/DB16180
    Investigational

    GP2 peptide is under investigation in clinical trial NCT00524277 (Vaccine Therapy in Treating Patients With Breast Cancer).